- Correction and Retractions / Republications and Version control
The journal discusses matters of debates as letters to the editor or as print/electronic correspondence, or as posts in a journal-sponsored online forum.
The journal considers all updates of previous publications (e.g., an updated systematic review or clinical guideline) as new publication rather than a version of a previously published article
A correction will be published in the journal if honest scientific error of fact is made The journal will follow ICMJE standards for publication of correction:
ii. Scientific misconduct, expressions of concern and retraction:
- The journal will publish a correction notice as soon as possible detailing changes from and citing the original publication; the correction will be on the electronic or numbered print page that is included in an electronic or a print Table of Contents to ensure proper indexing.
- The journal will also post a new article version with details of the changes from the original version and the date(s) on which the changes were
- The journal will archive all prior versions of the article. This archive will be made available to the reader on
- Previous electronic versions will prominently note that there are more recent versions of the
- The citation will be to the most recent version
- The journal will have the right to retract any published article if the scientific errors invalidate results, interpretations and
- Retraction with republication by the journal will only be consider when the errors are judged to be unintentional, but has led to a major change in the direction or significance of the results, interpretations, and In this case, if the changed version of the paper survives further review and editorial scrutiny, only then retraction with republication of the changed paper will be considered, with an explanation to allow full correction of the scientific literature.
The journal encourages reviewers / readers to comment on ethical issues, validity of submitted research paper, so as to identify subtle and/or blatant type of plagiarism, research and publication misconduct (e.g. inappropriate research design, incomplete detail on participant’s consent, data manipulation)
Scientific misconduct includes data fabrication and falsification. Data falsification includes deceptive manipulation of images and plagiarism.
Plagiarism is defined by HEC Plagiarism Policy as "taking and using the thoughts, writings, and inventions of another person as one's own". These include but are not limited to the following:
- Verbatim copying, near-verbatim copying, or purposely paraphrasing portions of another author's paper or unpublished report without citing the exact
- Copying elements of another author's paper, such as equations or illustrations that are not common knowledge, or copying or purposely paraphrasing sentences without citing the
- Verbatim copying portions of another author's paper or from reports by citing but not clearly differentiating what text has been copied (e.g. not applying quotation marks correctly) and /or not citing the source
- The unacknowledged use of computer programs, mathematical / computer models / algorithms, computer software in all forms, macros, spreadsheets, web pages, databases, mathematical deviations and calculations, designs / models / displays of any sort, diagrams, graphs, tables, drawings, works of art of any sort, fine art pieces or artifacts,
digital images, computer-aided design drawings, GIS files, photographs, maps, music / composition of any sort, posters, presentations and tracing.
- Self-plagiarism that is, the verbatim or near-verbatim re-use of significant portions of one's own copyrighted work without citing the original
The journal carries objective check through Turnitin and/or searching for similar titles to the submitted research paper. The journal will carry out individual assessment of each case of alleged scientific misconduct. An investigation committee headed by the editor will contact the corresponding author with his enclosed signed authorship statement and documentary evidence of misconduct, for an explanatory response. If the investigation proves scientific misconduct, then the journal will publish a retraction of the article. The journal will prominently label the retraction, on electronic or numbered print page or a print table of contents.
iii. Copy right:
The journal follows the Creative Common attribution non-commercial license.
iv. Duplicate submission:
The journal considers duplicate submission as submission of the same manuscript in same or different languages simultaneously to more than one journal.
The journal does not accept any duplicate submission. Authors will require a signed declaration stating that the manuscript has not been submitted elsewhere. All submitted manuscripts without such signed declaration will be rejected.
v. Duplicate and prior publication
The journal considers duplicate publication as a publication of a paper that overlaps substantially with one already published, but without clear, visible reference to the previous publication. The journal does not accept any duplicate publication.
The journal does not consider following as duplicate / prior publication:
vi. Acceptable secondary publication:
- A complete report that follows publication of a preliminary report, such as a letter to the editor, a preprint, or an abstract or poster displayed at a scientific
- Any paper that has been presented at a scientific meeting but was not published in full
- In the event of a public health emergency, information with immediate implications for public health should be disseminated without concern that this will preclude subsequent consideration for publication in a journal
The journal considers secondary publication as materials published in other journals or online justifiable and beneficial, especially when intended to disseminate important information to the widest possible audience (e.g., guidelines produced by government agencies and professional organizations in the same or a different language).
The journal will consider secondary publications for all other reasons if the following ICMJE conditions are met:
vii. Manuscript based on the same data base:
- The authors have received approval from the editors of both journals (the editor concerned with secondary publication must have access to the primary version)
- The priority of the primary publication is respected by a publication interval negotiated by both editors with the authors
- The paper for secondary publication is intended for a different group of readers; an abbreviated version could be
- The secondary version faithfully reflects the data and interpretations of the primary version.
- The secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part elsewhere—for example, with a note that might read, “This article is based on a study first reported in the [journal title, with full reference]”—and the secondary version cites the primary
- The title of the secondary publication should indicate that it is a secondary publication (complete or abridged republication or translation) of a primary publication
The journal considers all those manuscripts as independent submissions which are received from either separate research groups or from the same group analyzing the same data set (for example, from a public database, or systematic reviews or meta-analyses of the same evidence) because they may differ in their analytic methods, conclusions, or both.
The journal will give preference to the manuscript submitted first if the data interpretation and conclusions are similar.
Secondary analyses of clinical trial data should cite any primary publication and should clearly state that it contains secondary analyses/results, and use the same identifying trial registration number as the primary trial.
The journal has a mechanism for submitting comments, questions, or criticisms about published articles through a correspondence section or online forum.
Correspondence may be edited for length, grammatical correctness, and journal style and screen discourteous, inaccurate comments. Editors will have the prerogative to reject correspondence
The journal charge no fees required for manuscript processing or publishing material.
The journal considers supplements as collections of papers that deal with related issues or topics, published as a separate issue of the journal or as part of a regular issue.
The journal may publish supplements, theme issues, and special series from time to time. The same principles of authorship, conflict of interest, confidentiality, timeliness, peer-review, integrity, scientific misconduct and secondary publication, as discussed under relevant sections will also be applicable to supplements.
xi. Electronic publishing
The journal is published in electronic as well as print version and the policy applies equally to both.
The journal does not endorse or take responsibility or liability for any content, advertising, products, or other materials on the external linked sites.
The journal independently archive or use a credible repository for the historical record of published material.
The journal carries advertising on non-profit basis.
The editors will have full and final authority for approving print and online advertisements and for enforcing advertising policy.
xiii. Clinical trial registration:
The journal requires registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication.